Ahern V A, Roberts S J
Queensland Radium Institute, Royal Brisbane Hospital, Australia.
Australas Radiol. 1991 Aug;35(3):248-52. doi: 10.1111/j.1440-1673.1991.tb03017.x.
We report the presenting clinical characteristics, management, relapse patterns and survival of 17 patients with haemangiopericytoma treated at the Queensland Radium Institute, Australia from 1962 to 1989. Twelve patients were referred at the time of first diagnosis and were treated with curative intent. Three patients were treated with palliative intent when referred following initial diagnosis, and the remaining two patients were referred at the time of relapse. Disease was metastatic at presentation in 4 patients. Radiotherapy was used as a component of primary treatment of disease in 11 patients, in both patients referred for management of local relapse of haemangiopericytoma, and for palliation of metastatic disease developing in 3 patients. One patient received chemotherapy as part of initial treatment. Nine patients have died with survival from first treatment ranging from 3 to 139 months. All 8 surviving patients remain free of disease at 6 to 94 months from first treatment.
我们报告了1962年至1989年在澳大利亚昆士兰镭研究所接受治疗的17例血管外皮细胞瘤患者的临床特征、治疗情况、复发模式及生存情况。12例患者在首次诊断时被转诊并接受了根治性治疗。3例患者在初次诊断后转诊时接受了姑息性治疗，其余2例患者在复发时被转诊。4例患者初诊时即有转移。11例患者的疾病主要治疗采用了放疗，包括2例因血管外皮细胞瘤局部复发而转诊的患者以及3例出现转移性疾病进行姑息治疗的患者。1例患者在初始治疗时接受了化疗。9例患者已死亡，首次治疗后的生存时间为3至139个月。所有8例存活患者在首次治疗后的6至94个月均无疾病复发。
